ORCID as entered in ROS
https://orcid.org/0000-0002-4257-7620
Select Publications
Conference Papers
, 2013, 'Canagliflozin is effective and generally well tolerated in subjects with type 2 diabetes mellitus and Stage 3 chronic kidney disease', in DIABETOLOGIA, SPRINGER, SPAIN, Barcelona, pp. S382 - S382, presented at
, 2013, 'Renal safety and outcomes with linagliptin: meta-analysis of individual data for 5466 patients with type 2 diabetes', in DIABETOLOGIA, SPRINGER, SPAIN, Barcelona, pp. S364 - S364, presented at
, 2013, 'THE IMPACT OF HAEMODIAFILTRATION, HAEMOFILTRATION AND HAEMODIALYSIS ON CLINICAL OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS', in NEPHROLOGY, WILEY-BLACKWELL, pp. 28 - 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000323453000052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'High sensitivity cardiac troponin T and N-terminal pro-BNP predict cardiovascular events and death in patients with type 2 diabetes mellitus', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, NETHERLANDS, Amsterdam, pp. 301 - 301, presented at
, 2013, 'Canagliflozin (CANA) in Subjects With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled on Sulfonylurea (SU) Monotherapy: A CANVAS Substudy', in DIABETES, AMER DIABETES ASSOC, pp. A292 - A292, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209473601437&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2012, 'ANTICOAGULANTS FOR PREVENTION OF INTRAVASCULAR CATHETERS MALFUNCTION IN PATIENTS UNDERGOING HEMODIALYSIS: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED, CONTROLLED TRIALS', in NEPHROLOGY, WILEY-BLACKWELL, pp. 31 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307544400017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2012, 'Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment for Diabetic Nephropathy', in DIABETES, AMER DIABETES ASSOC, pp. A243 - A243, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209842902114&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2012, 'Effects of the DPP-4 inhibitor linagliptin on albuminuria in patients with type 2 diabetes and diabetic nephropathy', in DIABETOLOGIA, SPRINGER, pp. S20 - S21
, 2011, 'HOW RELIABLE IS VISIT-TO-VISIT CLINIC BLOOD PRESSURE VARIABILITY?', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Perth, pp. 498 - 498, presented at
, 2011, 'AGE AND CO-MORBIDITY, BUT NOT ESA DOSE OR HAEMOGLOBIN, ARE IMPORTANT ASSOCIATIONS WITH MORTALITY IN A PROSPECTIVELY FOLLOWED COHORT OF DIALYSIS PATIENTS', in NEPHROLOGY, WILEY-BLACKWELL, pp. 63 - 63, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294977600152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2011, 'CIRCULATING BONE MORPHOGENETIC PROTEIN-7 (BMP7) AND TRANSFORMING GROWTH FACTOR-beta 1 (TGF beta 1) AS POTENTIAL BIOMARKERS FOR RENAL ENDPOINTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS', in NEPHROLOGY, WILEY-BLACKWELL, pp. 24 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294977600003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2011, 'OUTCOMES OF PATIENTS RECEIVING EXTENDED HOURS HAEMODIALYSIS (EHHD)', in NEPHROLOGY, WILEY-BLACKWELL, pp. 63 - 63, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294977600151&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2010, 'ASPIRIN BENEFIT INCREASES AS eGFR DECLINES: RESULTS FROM A RANDOMISED CONTROLLED TRIAL IN A HYPERTENSIVE POPULATION', in NEPHROLOGY, WILEY-BLACKWELL, pp. 49 - 49, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700087&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2010, 'FACTORS ASSOCIATED WITH SURVIVAL IN ELDERLY DIALYSIS PATIENTS', in NEPHROLOGY, WILEY-BLACKWELL, pp. 27 - 27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2010, 'OUTCOMES ASSOCIATED WITH EXTENDED HOURS HAEMODIALYSIS (EHHD)', in NEPHROLOGY, WILEY-BLACKWELL, pp. 38 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2010, 'URAEMIC NEUROPATHY REMAINS UBIQUITIOUS: RATIONALE AND FEASIBILITY OF THE FINESSE (FILTRATION IN THE NEUROPATHY OF END STAGE KIDNEY DISEASE SYMPTOM EVOLUTION) TRIAL', in NEPHROLOGY, WILEY-BLACKWELL, pp. 88 - 88, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700236&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2010, 'MANAGEMENT OF CHRONIC KIDNEY DISEASE IN AUSTRALIAN GENERAL PRACTICE (THE AUSHEART STUDY)', in NEPHROLOGY, WILEY-BLACKWELL, pp. 71 - 71
, 2009, 'THE BENEFITS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Sydney, pp. 1502 - 1502, presented at
, 2009, 'A COMPARISON OF CT GUIDED VERSUS REALTIME ULTRASOUND GUIDED PERCUTANEOUS RENAL BIOPSY', in NEPHROLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A49 - A49, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270272500182&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2009, 'EFFECT OF HOMOCYSTEINE LOWERING ON CLINICAL OUTCOMES IN PEOPLE WITH KIDNEY DISEASE: A META-ANALYSIS', in NEPHROLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A39 - A40, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270272500147&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2009, 'ASPIRIN BENEFIT INCREASES WITH DECLINING RENAL FUNCTION AMONG PEOPLE WITH HYPERTENSION', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, ITALY, Milan, pp. S178 - S178, presented at
, 2009, 'BLOOD PRESSURE LOWERING REDUCES CARDIOVASCULAR EVENTS AND MORTALITY IN DIALYSIS PATIENTS: A SYSTEMATIC REVIEW OF RANDOMISED CONTROLLED TRIALS', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, ITALY, Milan, pp. S181 - S181, presented at
, 2009, 'THE EFFECTS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ACCORDING TO BASELINE CARDIOVASCULAR RISK IN THE ADVANCE TRIAL', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, ITALY, Milan, pp. S314 - S314, presented at
, 2009, 'THE FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE HAS A GREATER EFFECT ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ALBUMINURIA', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, ITALY, Milan, pp. S179 - S179, presented at
, 2008, 'THE RELATIONSHIP BETWEEN PROTEINURIA AND CARDIOVASCULAR DISEASE: A SYSTEMATIC REVIEW', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, pp. 1116 - 1116, presented at
, 2008, 'INDEPENDENT IMPACT OF ALBUMINURIA AND KIDNEY FUNCTION ON CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES: RESULTS FROM THE ADVANCE TRIAL', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, pp. 1115 - 1115, presented at
, 2008, 'JOINT EFFECTS OF BLOOD PRESSURE LOWERING AND GLUCOSE CONTROL IN THE ADVANCE TRIAL', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, pp. 1103 - 1103, presented at
, 2008, 'How many deaths from heart disease and stroke could be avoided by a small reduction in population cholesterol levels?', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 603 - 603, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208702503119&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2008, 'RENOPROTECTION WITH PERINDOPRIL-INDAPAMIDE BELOW CURRENT RECOMMENDED BLOOD PRESSURE TARGETS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: RESULTS OF THE ADVANCE TRIAL', in NEPHROLOGY, WILEY-BLACKWELL, pp. A121 - A121, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652600086&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2008, 'TWENTY YEAR CANCER OUTCOMES OF A RANDOMIZED TRIAL OF IMMUNOSUPPRESSION IN KIDNEY TRANSPLANT RECIPIENTS: RESULTS OF THE AUSTRALIAN MULTICENTRE TRIAL OF CYCLOSPORINE WITHDRAWAL', in NEPHROLOGY, WILEY-BLACKWELL, pp. A119 - A119, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652600079&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2008, 'Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: Results of the ADVANCE trial', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, GERMANY, Berlin, pp. S189 - S189, presented at
, 2008, 'Proteinuria is associated with a 50% increased risk of coronary heart disease: a meta-analysis of prospective cohort studies', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 593 - 593
, 2008, 'THE RENAL CHARACTERISTICS OF PATIENTS WITH A HISTORY OF LITHIUM EXPOSURE AS DETERMINED BY FORMAL RENAL FUNCTION TESTING', in NEPHROLOGY, WILEY-BLACKWELL, pp. A145 - A145
, 2007, 'LOWER BLOOD PRESSURE AND THE RISK OF STROKE IN CHRONIC KIDNEY DISEASE: RESULTS OF THE PROGRESS TRIAL', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Adelaide, pp. 173 - 173, presented at
, 2007, '20 YEAR OUTCOMES OF THE AUSTRALIAN MULTICENTRE RANDOMISED TRIAL OF CYCLOSPORINE WITHDRAWAL IN RENAL TRANSPLANTATION', in NEPHROLOGY, WILEY-BLACKWELL, pp. A19 - A19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2007, 'THE EFFICACY OF LOWER BLOOD PRESSURE GOALS ON THE PREVENTION OF STROKE IN CHRONIC KIDNEY DISEASE: DATA FROM THE PROGRESS STUDY', in NEPHROLOGY, WILEY-BLACKWELL, pp. A31 - A31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500122&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2007, '20 year outcomes of the Australian multicentre randomised trial of cyclosporine withdrawal in renal transplantation.', in AMERICAN JOURNAL OF TRANSPLANTATION, BLACKWELL PUBLISHING, CA, San Francisco, pp. 206 - 207, presented at
, 2007, 'PROTEINURIA AS A PREDICTOR OF CORONARY HEART DISEASE - A SYSTEMATIC REVIEW', in NEPHROLOGY, WILEY-BLACKWELL, pp. A31 - A31
, 2007, 'PROTEINURIA AS A PREDICTOR OF STROKE - A SYSTEMATIC REVIEW', in NEPHROLOGY, WILEY-BLACKWELL, pp. A31 - A31
, 2006, 'COST EFFECTIVENESS OF SCREENING FOR THE EARLY DIAGNOSIS AND TREATMENT OF RISK FACTORS FOR CHRONIC KIDNEY DISEASE: A MARKOV MONTE CARLO MICROSIMULATION USING MARCK-E (MODEL FOR THE ASSESSMENT OF RISK FACTORS FOR CHRONIC KIDNEY DISEASE - ECONOMICS)', in NEPHROLOGY, WILEY-BLACKWELL, pp. A9 - A9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652400034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2006, 'THE RELATIONSHIP BETWEEN CHRONIC KIDNEY DISEASE AND INDIVIDUAL-LEVEL SOCIOECONOMIC FACTORS: THE THREE COUNTRY KIDNEY DISEASE STUDY (3CKD)', in NEPHROLOGY, WILEY-BLACKWELL, pp. A13 - A14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652400053&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2006, 'THE ROLE OF NOCTURNAL HAEMODIALYSIS AND ARTERIAL STIFFNESS', in NEPHROLOGY, WILEY-BLACKWELL, pp. A30 - A30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652400121&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2006, 'Reductions in the risks of vascular events and stroke in patients with and without chronic kidney disease; New data from the PROGRESS trial', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, pp. 1475 - 1475, presented at
, 2006, 'REDUCTIONS IN THE RISKS OF VASCULAR EVENTS AND STROKE IN PATIENTS WITH AND WITHOUT CHRONIC KIDNEY DISEASE; NEW DATA FROM THE PROGRESS TRIAL', in NEPHROLOGY, WILEY-BLACKWELL, pp. A21 - A21
, 2006, 'THE PREDICTIVE ABILITY OF DIFFERENT MEASURES OF KIDNEY FUNCTION: NEW DATA FROM THE PROGRESS STUDY', in NEPHROLOGY, WILEY-BLACKWELL, pp. A46 - A46
, 2005, 'Dialysis adequacy (HD) guidelines: Dose of haemodialysis', in Nephrology, pp. S61 - S63, http://dx.doi.org/10.1111/j.1440-1797.2005.00464_1.x
, 2003, 'Sirolimus: A single center experience in combination with calcineurin inhibitors', in Transplantation Proceedings, pp. S99 - S104, http://dx.doi.org/10.1016/S0041-1345(03)00219-7
Conference Posters
, 2022, 'POS-546 EFFICACY AND SAFETY OF IPTACOPAN IN IgA NEPHROPATHY: RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 2 STUDY AT 6 MONTHS', Vol. 7, pp. S236 - S236, http://dx.doi.org/10.1016/j.ekir.2022.01.577
, 2020, '1130-P: Mediators of the Effects of Canagliflozin (CANA) on Heart Failure (HF) and CV Death in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)', ELECTR NETWORK, Vol. 69, presented at 80th Scientific Sessions of the American-Diabetes-Association (ADA), ELECTR NETWORK, 12 June 2020 - 16 June 2020, http://dx.doi.org/10.2337/db20-1130-p
, 2020, 'The Redox Balance Predicts Both Cardiovascular (CV) and Renal Outcomes in CANVAS', ELECTR NETWORK, Vol. 69, presented at 80th Scientific Sessions of the American-Diabetes-Association (ADA), ELECTR NETWORK, 12 June 2020 - 16 June 2020, http://dx.doi.org/10.2337/db20-139-LB
Filter by type
https://orcid.org/0000-0002-4257-7620